We are live on ! Find out more
CELG

Celgene Corp
CELG

Delisted

CELG was delisted on the 20th of November, 2019.

866 hedge funds and large institutions have $39.2B invested in Celgene Corp in 2013 Q2 according to their latest regulatory filings, with 866 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less call options, than puts

Call options by funds: $605M | Put options by funds: $682M

Holders
866
Holders Change
+866
Holders Change %
% of All Funds
28.26%
Holding in Top 10
55
Holding in Top 10 Change
+55
Holding in Top 10 Change %
% of All Funds
1.8%
New
866
Increased
Reduced
Closed
Calls
$605M
Puts
$682M
Net Calls
-$77.2M
Net Calls Change
-$77.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$331M +$341M +5,660,660 New
BA
27
BlackRock Advisors
Delaware
$320M +$329M +5,466,024 New
DCP
28
DSM Capital Partners
Florida
$318M +$327M +5,432,978 New
AllianceBernstein
29
AllianceBernstein
Tennessee
$312M +$321M +5,333,520 New
GVI
30
Green Valley Investors
Delaware
$292M +$301M +5,000,000 New
SAC
31
Smith Affiliated Capital
New York
$283M
UBS AM
32
UBS AM
Illinois
$275M +$283M +4,699,424 New
MAA
33
Managed Account Advisors
New Jersey
$274M +$282M +4,689,426 New
Westfield Capital Management
34
Westfield Capital Management
Massachusetts
$273M +$280M +4,659,688 New
Renaissance Technologies
35
Renaissance Technologies
New York
$262M +$270M +4,478,538 New
Massachusetts Financial Services
36
Massachusetts Financial Services
Massachusetts
$261M +$269M +4,463,464 New
American Century Companies
37
American Century Companies
Missouri
$260M +$268M +4,451,954 New
Allianz Asset Management
38
Allianz Asset Management
Germany
$257M +$264M +4,391,776 New
BB
39
BB Biotech
Switzerland
$252M +$259M +4,300,372 New
Morgan Stanley
40
Morgan Stanley
New York
$237M +$244M +4,049,716 New
Goldman Sachs
41
Goldman Sachs
New York
$215M +$221M +3,667,380 New
Legal & General Group
42
Legal & General Group
United Kingdom
$213M +$219M +3,639,992 New
Prudential Financial
43
Prudential Financial
New Jersey
$212M +$219M +3,632,626 New
Bank of America
44
Bank of America
North Carolina
$209M +$216M +3,581,506 New
PI
45
Putnam Investments
Massachusetts
$207M +$213M +3,546,412 New
ClearBridge Investments
46
ClearBridge Investments
New York
$204M +$210M +3,487,882 New
AAMU
47
Amundi Asset Management US
Massachusetts
$189M +$194M +3,228,240 New
CS
48
Credit Suisse
Switzerland
$183M +$188M +3,128,530 New
Charles Schwab
49
Charles Schwab
California
$181M +$183M +3,047,324 New
Lord, Abbett & Co
50
Lord, Abbett & Co
New Jersey
$172M +$177M +2,941,538 New

CELG Hedge Fund Activity: Q2 2013 in Review

866 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q2 2013, worth a combined $39.2B.

Buyers outnumbered sellers: 866 funds opened new CELG positions and 0 closed out — a net gain of 866 holders — while 0 added to existing stakes and 0 trimmed.

  • 866 institutional investors held Celgene Corp (CELG) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $39.2B of Celgene Corp stock for Q2 2013.
  • 866 funds opened new Celgene Corp positions in Q2 2013 and 0 closed out, a net change of +866 holders.

Based on aggregated 13F filings for Q2 2013.